-
公开(公告)号：KR101447657B1
公开(公告)日：2014-10-07
申请号：KR1020130007792
申请日：2013-01-24
Applicant: 한림대학교 산학협력단
Abstract: 본 발명은 항암 조성물에 관한 것으로, 전나무(
Abies
holophylla
MAX ) 잎 에탄올 추출물을 유효성분으로 함유하는 항암 조성물 및 전나무(
Abies
holophylla
MAX ) 잎 에탄올 추출물을 디클로로메탄으로 분획하여 수득된 디클로로메탄 분획물을 유효성분으로 함유하는 항암 조성물을 제공한다.-
公开(公告)号：KR1020130010061A
公开(公告)日：2013-01-25
申请号：KR1020110070611
申请日：2011-07-15
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: A Populus timentiglandulosa T. Lee bark extract with an anti-inflammation activity and a composition containing the same are provided to ensure excellent anti-inflammatory activity under cell apoptotic concentration. CONSTITUTION: A Populus timentiglandulosa T. Lee bark extract with an anti-inflammatory activity is prepared by extracting Populus timentiglandulosa T. Lee barks using hot water. The extract is prepared by extracting Populus timentiglandulosa T. Lee barks using hot water and fractioning with ethyl acetate. A composition for anti-inflammation contains the extract as an active ingredient. [Reference numerals] (AA) Populus timentiglandulosa T. Lee(20ug/mL)
Abstract translation: 目的：提供具有抗炎活性的山杨（Tumiglanlanloslosa）李氏树皮提取物和含有其的组合物，以确保在细胞凋亡浓度下优异的抗炎活性。 构成：通过使用热水提取杨树杨树皮栗子制备具有抗炎活性的山杨（Tulusiglandulosa）李氏树皮提取物。 提取物是通过使用热水提取杨树杨树皮，并用乙酸乙酯分级制备的。 用于抗炎的组合物含有提取物作为活性成分。 （参考号）（AA）白杨木杨（Lee）（20ug / mL）
-
公开(公告)号：KR1020100077553A
公开(公告)日：2010-07-08
申请号：KR1020080135520
申请日：2008-12-29
Applicant: 주식회사 바이오뉴트라 , 한림대학교 산학협력단
Abstract: PURPOSE: A composition containing licochalcone A is provided to prevent and treat sepsis without toxic effects. CONSTITUTION: A pharmaceutical composition for preventing and treating sepsis contains licochalcone A or a pharmaceutically acceptable salt thereof as an active ingredient. Licochalcone A is a major flavonoid isolated from Glycyrrhizae radix. The content of licochalcone A is 0.01-99.9 weight%. The pharmaceutical composition is used in the form of a powder, granule, tablet, capsule, suspension, emulsion, syrup, aerosol, external use formulation, suppository, or injection.
Abstract translation: 目的：提供含有吡草酮A的组合物，以预防和治疗无毒性的败血症。 构成：用于预防和治疗败血症的药物组合物含有吡罗昔酮A或其药学上可接受的盐作为活性成分。 Licochalcone A是从甘草中分离的主要类黄酮。 查尔酮A的含量为0.01-99.9重量％。 药物组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，气雾剂，外用制剂，栓剂或注射剂的形式使用。
-
公开(公告)号：KR101434409B1
公开(公告)日：2014-08-26
申请号：KR1020120139515
申请日：2012-12-04
Applicant: 한림대학교 산학협력단
Abstract: 본 발명은 항염증용 조성물에 관한 것으로, 전나무(
Abies
holophylla
MAX ) 목질부 에탄올 추출물을 유효성분으로 함유하는 항염증용 조성물 및 전나무(
Abies
holophylla
MAX ) 목질부 에탄올 추출물을 디클로로메탄으로 분획하여 수득된 디클로로메탄 분획물을 유효성분으로 함유하는 항염증용 조성물을 제공한다.-
公开(公告)号：KR1020140095191A
公开(公告)日：2014-08-01
申请号：KR1020130007792
申请日：2013-01-24
Applicant: 한림대학교 산학협력단
CPC classification number: A61K36/15 , A23L33/105 , A23V2002/00 , A23V2200/308
Abstract: The present invention relates to an anti-cancer composition. Provided are an anti-cancer composition containing an ethanol extract of abies holophylla max leaves as an active ingredient, and an anti-cancer composition containing a dichloromethane faction obtained by fractionizing the ethanol extract of abies holophylla max leaves into dichloromethane.
Abstract translation: 本发明涉及抗癌组合物。 本发明提供含有作为活性成分的叶绿素的乙醇提取物的抗癌药物，以及含有通过将乙酸乙酯提取物分离到二氯甲烷中而获得的二氯甲烷组的抗癌组合物。
-
Patent Agency Ranking
公开(公告)号：KR101284279B1
公开(公告)日：2013-07-08
申请号：KR1020110070610
申请日：2011-07-15
Applicant: 한림대학교 산학협력단
Abstract: 본 발명은 암전이 억제 활성을 나타내는 청시닥 나무 수피 추출물 및 이를 함유하는 조성물에 관한 것으로, 청시닥 나무(
Acer
barbinerve
Max ) 목질부의 추출물에서는 암전이 억제 활성이 미미함에 반해, 본 발명의 청시닥 나무(
Acer
barbinerve
Max ) 수피(樹皮)의 추출물은 세포 사멸 농도 이하에서 현저한 암전이 억제 활성을 나타냈다.-
公开(公告)号：KR101284277B1
公开(公告)日：2013-07-08
申请号：KR1020110070609
申请日：2011-07-15
Applicant: 한림대학교 산학협력단
Abstract: 본 발명은 항염증 활성을 나타내는 청시닥 나무 수피 추출물 및 이를 함유하는 조성물에 관한 것으로, 청시닥 나무(
Acer
barbinerve
Max ) 목질부의 추출물에서는 항염증 활성이 미미함에 반해, 본 발명의 청시닥 나무(
Acer
barbinerve
Max ) 수피(樹皮)의 추출물은 세포 사멸 농도 이하에서 현저한 항염증 활성을 나타냈다.-
公开(公告)号：KR1020140071671A
公开(公告)日：2014-06-12
申请号：KR1020120139515
申请日：2012-12-04
Applicant: 한림대학교 산학협력단
CPC classification number: A61K36/15 , A23L33/105 , A23V2002/00 , A23V2200/324
Abstract: The present invention relates to an anti-inflammatory composition. The present invention provides an anti-inflammatory composition containing ethanol extract of Abies holophylla MAX xylem as an active ingredient and an anti-inflammatory composition containing a dichloromethane fraction obtained by fractionating ethanol extract of Abies holophylla MAX xylem with dichloromethane as an active ingredient.
Abstract translation: 本发明涉及抗炎组合物。 本发明提供一种抗氧化组合物，其含有作为活性成分的枸杞子乙醇提取物和含有二氯甲烷馏分的抗炎组合物，所述二氯甲烷馏分用二氯甲烷作为活性成分分馏得到的乙酸乙酯提取物。
-
公开(公告)号：KR1020130009910A
公开(公告)日：2013-01-24
申请号：KR1020110070609
申请日：2011-07-15
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: A composition containing an Acer barbinerve Max bark extract with anti-inflammation activity is provided to enhance anti-inflammation activity. CONSTITUTION: An extract with anti-inflammation activity is prepared by extracting an Acer barbinerve Max bark part with hot water and fractioning with ethyl acetate. A composition for anti-inflammation contains the extract as an active ingredient. [Reference numerals] (AA) Bark; (BB) Lignum; (CC) Acer barbinerve Max(20ug/mL)
Abstract translation: 目的：提供含有Acer barbinerve具有抗炎活性的Max树皮提取物以增强抗炎活性。 构成：通过用热水提取Acer barbinerve Max树皮部分并用乙酸乙酯分级制备具有抗炎活性的提取物。 用于抗炎的组合物含有提取物作为活性成分。 （附图标记）（AA）树皮; （BB）Lignum; （CC）Acer barbinerve Max（20ug / mL）
-
公开(公告)号：KR1020130010100A
公开(公告)日：2013-01-25
申请号：KR1020110070610
申请日：2011-07-15
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: A composition containing an Acer barbinerve Max extract which suppresses cancer metastasis is provided to remarkably suppress cancer metastasis under cell apoptotic concentration. CONSTITUTION: An Acer barbinerve Max extract is prepared from Acer barbinerve Max barks using hot water and suppresses cancer metastasis. The extract is also prepared by extracting Acer barbinerve Max barks with hot water and fractioning with ethyl acetate. An anticancer agent contains the extract as an active ingredient. [Reference numerals] (AA) Bark; (BB) Lignum; (CC) Acer barbinerve Max(20ug/mL)
Abstract translation: 目的：提供抑制癌症转移的含有Acer barbinerve Max提取物的组合物，以显着抑制细胞凋亡浓度下的癌症转移。 构成：使用热水从Acer barbinerve Max barks制备Acer barbinerve Max提取物，抑制癌症转移。 提取物也是用热水提取Acer barbinerve Max树皮并用乙酸乙酯分级制备的。 抗癌剂含有提取物作为活性成分。 （附图标记）（AA）树皮; （BB）Lignum; （CC）Acer barbinerve Max（20ug / mL）
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.021 seconds)
